Análisis de la cuota de mercado de Cartesian Therapeutics para marzo 2026

General Policy Statement The US Food and Drug Administration (FDA) has established criteria for the provision of investigational medicines to patients outside of clinical trials, called “Expanded Access,” “Compassionate Use,” “Early Access,” or “Emergency Use.” Patients who seek access to investigational medicines outside of an established clinical study and prior to health authority marketing authorization […]